What Are the Benefits of Using Bacillus amyloliquefaciens as a Fungicide?

Fungal diseases can damage roots, leaves, flowers, fruits, and harvested produce. Although conventional fungicides remain important in many disease-management programs, growers are increasingly interested in biological tools that can reduce dependence on synthetic inputs.

Selected strains of Bacillus amyloliquefaciens have been developed as microbial biofungicides. Their main advantage is that they can suppress plant pathogens through several complementary mechanisms, including antimicrobial metabolite production, competition for space and nutrients, root or leaf-surface colonization, and stimulation of plant defenses.

However, these benefits are strain- and product-specific. Not every B. amyloliquefaciens isolate has the same antifungal capabilities, and results can vary with the crop, pathogen, formulation, application timing, weather, and production system.

What Is Bacillus amyloliquefaciens?

Bacillus amyloliquefaciens is a Gram-positive, rod-shaped, spore-forming bacterium found in soil and plant-associated environments. It is recognized as a valid bacterial species in the List of Prokaryotic names with Standing in Nomenclature.

Certain strains can establish themselves in the rhizosphere, on plant roots, or on above-ground plant surfaces. These strains may produce biologically active compounds that interfere with fungal pathogens or help plants respond more effectively to infection.

An important taxonomy note is necessary when evaluating the research. Some plant-associated strains formerly identified as B. amyloliquefaciens subsp. plantarum have been reclassified as Bacillus velezensis. For example, the widely researched strain FZB42 is now classified as B. velezensis. Older scientific papers and regulatory labels may retain the former name, so strain identity should always be checked before transferring a research result to another product or organism. This reclassification is explained in a phylogenomic study by Dunlap and colleagues.

For more organism-level information, visit IndoGulf BioAg’s page on Bacillus amyloliquefaciens.

How Does Bacillus amyloliquefaciens Work as a Biofungicide?

A strain-identified Bacillus amyloliquefaciens fungicide may act through several direct and indirect mechanisms.

1. Production of antifungal lipopeptides

Selected strains produce cyclic lipopeptides such as iturins, fengycins, and surfactins. These compounds do not all perform the same function.

Iturins and fengycins can interact with fungal cell membranes, disrupt membrane integrity, and inhibit spore germination or mycelial growth. Surfactins may provide weaker direct antifungal activity in some systems, but they can support surface colonization, biofilm development, and plant-defense signaling.

The amount and combination of these metabolites vary considerably among strains. Therefore, the presence of the species name alone does not confirm that a product will produce every beneficial lipopeptide.

2. Competition for nutrients and infection sites

Plant pathogens need nutrients and suitable spaces in which to germinate, grow, and infect plant tissue. A well-adapted beneficial strain can colonize root surfaces, flowers, leaves, or wounds before a pathogen becomes established.

By occupying these sites and consuming locally available nutrients, the bacterium can make conditions less favorable for pathogen development. Root-associated Bacillus species may also form biofilms—organized microbial communities surrounded by a protective matrix—which can improve their ability to remain near the plant. Root colonization and competition are recognized components of Bacillus-based biological control, although their effectiveness depends strongly on environmental conditions (Zhang et al., 2023).

3. Production of enzymes and volatile compounds

Some strains produce enzymes such as chitinases, glucanases, and proteases that may degrade structural components associated with fungal cells. Selected strains also release volatile organic compounds capable of restricting fungal growth under laboratory or controlled conditions.

These mechanisms are scientifically promising, but laboratory inhibition does not automatically predict field-level disease control. The metabolites must be produced at effective concentrations under actual crop conditions.

4. Activation of plant defenses

Certain Bacillus strains can prime induced systemic resistance. Rather than directly killing every pathogen, the beneficial bacterium stimulates defense-related signaling and prepares the plant to react more rapidly when infection occurs.

This response may involve defense enzymes, antioxidant pathways, cell-wall reinforcement, and pathogenesis-related proteins. A 2024 review supplied for this content describes how rhizosphere microorganisms, including selected Bacillus strains, can influence plant-defense pathways (Thepbandit and Athinuwat, 2024).

Major Benefits of Using Bacillus amyloliquefaciens as a Fungicide

Multiple modes of action

Many conventional fungicides primarily affect a defined biochemical target. Selected biological strains can combine direct antifungal activity, nutrient competition, surface colonization, and plant-defense priming.

This makes a microbial biofungicide a useful way to diversify an integrated disease-management program. It should not, however, be described as resistance-proof. Biological and conventional products must still be used according to resistance-management recommendations and their approved labels.

Preventive protection

Bacillus-based fungicides are generally most valuable when applied before infection or during the earliest stages of disease development. Early application allows the beneficial organism to occupy potential infection sites before pathogen populations become established.

This preventive behavior can be useful for protecting seedlings, roots, flowers, foliage, wounds, and harvested produce, depending on the registered product and target disease.

Suitability for integrated pest management

A strain-specific Bacillus amyloliquefaciens fungicide can be combined with practices such as:

• Disease-resistant varieties

• Crop rotation

• Sanitation and residue management

• Suitable irrigation scheduling

• Canopy and humidity management

• Disease monitoring and forecasting

• Compatible biological or conventional treatments

Integrating several tools usually provides more dependable disease management than expecting one microbial treatment to work under every condition.

Spore-forming ability

Bacillus bacteria produce endospores that tolerate environmental stress better than the active vegetative cells of many non-spore-forming microorganisms. This characteristic can make them suitable for commercial production, storage, transportation, and application.

Nevertheless, spore formation does not guarantee unlimited shelf life. Moisture, temperature, carrier materials, packaging, and formulation quality influence viability and performance. Product storage instructions and expiry dates must therefore be followed.

Potential to reduce dependence on synthetic fungicides

When a registered biological treatment successfully replaces or reduces a conventional application, it may help lower dependence on synthetic crop-protection inputs. This can be particularly valuable in integrated or residue-conscious production systems.

A biological origin does not automatically make every strain or formulation harmless. Human, environmental, and non-target safety must be assessed at the product and use-pattern level. Regulatory authorization in one country also does not authorize use in another.

Possible plant-health benefits

Some strains studied for biological control also exhibit plant-growth-associated traits, such as root colonization or nutrient mobilization. Healthier root systems may help plants tolerate environmental and disease-related stress.

These benefits should remain separate from fungicide claims unless they have been demonstrated for the exact strain, formulation, crop, and application method.

What Does Field Research Show?

Research results demonstrate both the potential and the limitations of these biofungicides.

In five replicated field trials conducted over three years, a commercial formulation reported as B. amyloliquefaciens strain D747 reduced white mold incidence in snap and dry beans. Disease incidence was not significantly different from conventional fungicide standards in those trials, although yield responses were variable (Pethybridge et al., 2019).

A review of the B. amyloliquefaciens operational group identified antifungal lipopeptides, volatile compounds, nutrient competition, and induced resistance as important mechanisms in postharvest disease management. The authors also emphasized gaps in efficacy consistency and host-range validation (Calvo et al., 2022).

Not every experiment produces strong control. In citrus mal secco research, commercial B. amyloliquefaciens-labelled products reduced some disease measurements but were generally less effective than standard fungicides, and strain D747 did not significantly reduce one symptom-severity endpoint at a particular assessment (La Spada et al., 2022). A separate field study reported that tested microbial and biochemical biofungicides were ineffective against Alternaria black spot on organic kale.

These results show why a biological fungicide should be selected for a specific crop–pathogen combination rather than on the bacterial species name alone.

How to Obtain the Best Results

Growers should use only registered, strain-identified formulations and follow the complete product label. The U.S. Environmental Protection Agency, for example, lists strain D747 as a specific biopesticide active ingredient, illustrating that regulatory evaluation is conducted at the strain level rather than for every member of the species (US EPA).

For dependable performance:

• Apply preventively or at the labelled disease stage.

• Achieve thorough coverage of the target plant surface or root zone.

• Use the approved rate, water volume, interval, and application route.

• Store the product under its specified conditions.

• Check label-approved compatibility before tank mixing.

• Avoid assuming that every chemical pesticide, disinfectant, fertilizer, or extreme-pH solution is compatible with live spores.

• Combine the biofungicide with sanitation, monitoring, resistant varieties, and other integrated practices.

• Evaluate performance under local crop and climate conditions.

Frequently Asked Questions

Is Bacillus amyloliquefaciens a chemical fungicide?

No. It is a bacterial species. Registered products containing selected strains or their fermentation components may function as microbial biofungicides. The legal classification depends on the formulation, label, claims, and national regulations.

Which fungal diseases can it control?

Selected strains have been investigated against pathogens associated with white mold, Fusarium diseases, Botrytis diseases, Rhizoctonia diseases, postharvest rots, and other fungal infections. This does not mean that every strain controls every disease. The product label should identify the approved crops and pathogens.

Can it replace conventional fungicides completely?

Not in every crop or disease situation. Some field studies have reported useful control, while others have found weaker or inconsistent results. It is generally most dependable as part of an integrated program.

Is Bacillus amyloliquefaciens safe for plants?

Appropriately formulated and registered strains are intended for labelled agricultural use, but crop safety, dose, formulation, and compatibility remain product-specific. A small-scale compatibility test may be appropriate when permitted by the label.

Can it be mixed with other crop-protection products?

Compatibility cannot be assumed. Some fungicides, bactericides, disinfectants, highly acidic or alkaline solutions, and certain tank-mix conditions may reduce bacterial viability. Follow the label or obtain written compatibility guidance from the manufacturer.

Conclusion

The principal benefits of using Bacillus amyloliquefaciens as a fungicide are its multiple potential modes of action, preventive surface colonization, ability to prime plant defenses, spore-based formulation possibilities, and usefulness in integrated crop protection.

Its effectiveness is not universal. Performance depends on having the correct strain, a stable formulation, suitable application timing, an approved crop–pathogen match, and favorable environmental conditions. When these factors are addressed, a strain-specific Bacillus amyloliquefaciens biofungicide can become a valuable component of a more diverse and sustainable disease-management program.

Technical disclaimer: This article describes published research on selected strains. It does not establish the performance, registration, safety, compatibility, or recommended dosage of any IndoGulf BioAg product. Product claims require verified strain identity, formulation data, local authorization, and crop-specific trials.